title: The first year of the Venlo percutaneous coronary intervention program: procedural and 6-month clinical outcomes.
abstract: OBJECTIVE
  Analysis of the first results of off-site percutaneous coronary interventions (PCI) and fractional flow reserve (FFR) measurements at VieCuri Medical Centre for Northern Limburg in Venlo.
  
  
  BACKGROUND
  Off-site PCI is accepted in the European and American Cardiac Guidelines as the need for PCI increases and it has been proven to be a safe treatment option for acute coronary syndrome.
  
  
  METHODS
  Retrospective cohort study reporting characteristics, PCI and FFR specifications, complications and 6-month follow-up for all consecutive patients from the beginning of off-site PCI in Venlo until July 2012. If possible, the data were compared with those of Medical Centre Alkmaar, the first off-site PCI centre in the Netherlands.
  
  
  RESULTS
  Of the 333 patients, 19 (5.7 %) had a procedural complication. At 6 months, a major adverse cardiovascular event (MACE) occurred in 43 (13.1 %) patients. There were no deaths or emergency surgery related to the PCI or FFR procedures. There was no significant difference in occurrence of a MACE or adverse cerebral event between the Alkmaar and Venlo population in the 30-day follow-up.
  
  
  CONCLUSIONS
  This study demonstrates off-site PCI at VieCuri Venlo to have a high success rate. Furthermore, there was a low complication rate, low MACE and no procedure-related mortality.
authors: Department of Cardiology, VieCuri Medical Center Venlo, Tegelseweg 210, 5912BL, Venlo, the Netherlands, k.mol@student.maastrichtuniversity.nl.
authors: K A
authors: KA
authors: Mol
authors: B M
authors: BM
authors: Rahel
authors: F
authors: F
authors: Eerens
authors: S
authors: S
authors: Aydin
authors: R P Th
authors: RP
authors: Troquay
authors: J G
authors: JG
authors: Meeder
references: J Invasive Cardiol. 2002 Feb;14(2):72-9
references: 11818641
references: Am J Cardiol. 2008 Jan 1;101(1):53-7
references: 18157965
references: Circulation. 2002 Oct 29;106(18):2346-50
references: 12403665
references: J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122
references: 22070834
references: Am J Ther. 2011 Mar-Apr;18(2):e22-8
references: 19918168
references: Circulation. 2013 Jan 29;127(4):e362-425
references: 23247304
references: Am J Cardiol. 2005 May 1;95(9):1091-3
references: 15842979
references: Eur Heart J. 2012 Oct;33(20):2569-619
references: 22922416
references: Int J Cardiol. 2009 Feb 6;132(1):59-65
references: 18241941
references: Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8
references: 22319067
references: J Am Coll Cardiol. 2003 Jan 1;41(1):26-32
references: 12570940
references: Am Heart J. 2004 Oct;148(4):676-83
references: 15459600
references: J Am Coll Cardiol. 2006 Apr 18;47(8):1713-21
references: 16631012
references: Circulation. 2001 Jun 19;103(24):3019-41
references: 11413094
references: Am Heart J. 2006 Nov;152(5):888-95
references: 17070152
references: Circulation. 1987 Jul;76(1):142-54
references: 3109764
references: Heart. 2005 Dec;91 Suppl 6:vi1-27
references: 16365340
references: N Engl J Med. 2009 Jan 15;360(3):213-24
references: 19144937
references: J Invasive Cardiol. 2012 Jul;24(7):309-15
references: 22781467
references: Crit Pathw Cardiol. 2005 Jun;4(2):98-106
references: 18340191
references: JAMA. 2004 Oct 27;292(16):1961-8
references: 15507581
references: Catheter Cardiovasc Interv. 2007 Mar 1;69(4):471-8
references: 17278155
references: J Am Coll Cardiol. 2005 Dec 6;46(11):2004-9
references: 16325032
references: Eur Heart J. 2001 Sep;22(18):1733-40
references: 11511123
references: JAMA. 2002 Apr 17;287(15):1943-51
references: 11960536
references: Circulation. 1988 Aug;78(2):486-502
references: 2969312
references: J Am Coll Cardiol. 1999 Sep;34(3):674-80
references: 10483947